Importantly, the attenuated AT fibrosis contributed to improved glucose intolerance and insulin resistance imposed by HFD-induced obesity (Fig. 7d, e), indicating that the deletion of YAP/TAZ could reduce AT fibrosis and associated metabolic dysfunction. The gene discussed is WWTR1; the disease is obesity disorder.